Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Rapid evidence review of the comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder.

Peterson K, Dieperink E, Anderson J, Boundy E, Ferguson L, Helfand M.

Psychopharmacology (Berl). 2017 Jun;234(11):1649-1661. doi: 10.1007/s00213-017-4622-9. Epub 2017 Apr 29. Review.

PMID:
28456840
2.

Cerebral ABC transporter-common mechanisms may modulate neurodegenerative diseases and depression in elderly subjects.

Pahnke J, Fröhlich C, Paarmann K, Krohn M, Bogdanovic N, Årsland D, Winblad B.

Arch Med Res. 2014 Nov;45(8):738-43. doi: 10.1016/j.arcmed.2014.10.010. Epub 2014 Nov 11.

PMID:
25446622
3.

MRP1 polymorphisms associated with citalopram response in patients with major depression.

Lee SH, Lee MS, Lee JH, Kim SW, Kang RH, Choi MJ, Park SJ, Kim SJ, Lee JM, Cole SP, Lee MG.

J Clin Psychopharmacol. 2010 Apr;30(2):116-25. doi: 10.1097/JCP.0b013e3181d2ef42.

PMID:
20520284
4.

The structure of the multidrug resistance protein 1 (MRP1/ABCC1). crystallization and single-particle analysis.

Rosenberg MF, Mao Q, Holzenburg A, Ford RC, Deeley RG, Cole SP.

J Biol Chem. 2001 May 11;276(19):16076-82. Epub 2001 Jan 22.

Supplemental Content

Loading ...
Support Center